For Release
FTC Closes Its Investigation Into Caremark Rxs Proposed Acquisition of Advance PCS
Transaction Involves Two U.S. Providers of Prescription Benefit Management Services
The Federal Trade Commission today announced that it has closed its antitrust investigation into Caremark Rx, Inc.’s proposed acquisition of Advance PCS, and that it has notified the companies of this decision. The transaction involves two providers of prescription benefit management (PBM) services in the United States. PBMs administer prescription benefits for most U.S. consumers under contracts with health plans or directly with employers.
As part of the FTC’s continuing effort to provide transparency in its decision-making process and to provide guidance about the application of the antitrust laws to mergers in this market, the Commission has issued a statement outlining its reasons for closing the investigation. The statement is available as a link to this press release on the FTC’s Web site.
The vote to close the investigation and issue the Commission statement was 5-0.
(FTC File No. 031-0239)
The Federal Trade Commission works to promote competition, and to protect and educate consumers. The FTC will never demand money, make threats, tell you to transfer money, or promise you a prize. You can learn more about how competition benefits consumers, file an antitrust complaint, or comment on a proposed merger. For the latest news and resources, follow the FTC on social media, subscribe to press releases, and read our blog.
Contact Information
202-326-2180